Patents by Inventor Marc Bigaud

Marc Bigaud has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers for Graft Rejection
    Publication number: 20120039868
    Abstract: Methods are disclosed for diagnosing rejection in a transplanted subject, monitoring rejection in a transplanted subject at risk thereof, preventing, inhibiting, reducing or treating rejection in a transplanted subject, or identifying agents for use in the prevention, inhibition, reduction or treatment of rejection, based on genes which are differentially expressed in transplanted subjects.
    Type: Application
    Filed: October 25, 2011
    Publication date: February 16, 2012
    Inventors: Marc Bigaud, Jeanne Kehren, Friedrich Raulf, Grazyna Wieczorek
  • BIOMARKERS FOR GRAFT REJECTION
    Publication number: 20090269334
    Abstract: Methods are disclosed for diagnosing rejection in a transplanted subject, monitoring rejection in a transplanted subject at risk thereof, preventing, inhibiting, reducing or treating rejection in a transplanted subject, or identifying agents for use in the prevention, inhibition, reduction or treatment of rejection, based on genes which are differentially expressed in transplanted subjects.
    Type: Application
    Filed: July 13, 2009
    Publication date: October 29, 2009
    Inventors: Marc Bigaud, Jeanne Kehren, Friedrich Raulf, Grazyna Wieczorek
  • USE OF ACCELERATED LYMPHOCYTE HOMING AGENTS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF DELAYED GRAFT FUNCTION
    Publication number: 20080015261
    Abstract: The invention relates to the use of an accelerated lymphocyte homing agent, e.g. a 2-amino-1,3-propanediol derivative, in reducing delayed graft function in a recipient of organ or tissue transplant.
    Type: Application
    Filed: September 26, 2007
    Publication date: January 17, 2008
    Inventors: Marc Bigaud, Volker Brinkmann, Tomasz Sablinski
  • Biomarkers for graft rejection
    Publication number: 20070111210
    Abstract: Methods are disclosed for diagnosing rejection in a transplanted subject, monitoring rejection in a transplanted subject at risk thereof, preventing, inhibiting, reducing or treating rejection in a transplanted subject, or identifying agents for use in the prevention, inhibition, reduction or treatment of rejection, based on genes which are differentially expressed in transplanted subjects.
    Type: Application
    Filed: December 2, 2004
    Publication date: May 17, 2007
    Inventors: Marc Bigaud, Jeanne Kehren, Friedrich Raulf, Grazyna Wieczorek
  • Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment of delayed graft function
    Publication number: 20040087662
    Abstract: The invention relates to the use of an accelerated lymphocyte homing agent, e.g. a 2-amino-1,3-propanediol derivative, in reducing delayed graft function in a recipient of organ or tissue transplant.
    Type: Application
    Filed: August 20, 2003
    Publication date: May 6, 2004
    Inventors: Marc Bigaud, Volker Brinkmann, Tomasz Sablinski
  • Phosphonomethyldipeptides and process for preparation thereof
    Patent number: 5608078
    Abstract: Dipeptide compounds and analogs thereof having a phosphonomethyl moiety are disclosed. These compounds inhibit Endothelin Converting Enzyme and are thus useful in treating conditions responsive to inhibition of production of Endothelin.
    Type: Grant
    Filed: November 13, 1995
    Date of Patent: March 4, 1997
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Hugues d'Orchymont, Marc Bigaud